Literature DB >> 15624097

Brain natriuretic peptide: microalbuminuria for cardiac disease and diabetes?

Per-Henrik Groop1, Merlin C Thomas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15624097     DOI： 10.1007/s00125-004-1611-4

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  10 in total

1.  Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy.

Authors:  P Poirier; P Bogaty; C Garneau; L Marois; J G Dumesnil
Journal:  Diabetes Care       Date:  2001-01       Impact factor: 19.112

Review 2.  Screening for and treating left-ventricular abnormalities in diabetes mellitus: a new way of reducing cardiac deaths.

Authors:  Allan D Struthers; Andrew D Morris
Journal:  Lancet       Date:  2002-04-20       Impact factor: 79.321

3.  Plasma N-terminal pro-brain natriuretic peptide as a major risk marker for cardiovascular disease in patients with type 2 diabetes and microalbuminuria.

Authors:  P Gaede; P Hildebrandt; G Hess; H-H Parving; O Pedersen
Journal:  Diabetologia       Date:  2004-12-24       Impact factor: 10.122

4.  Plasma N-terminal pro-brain natriuretic peptide as an independent predictor of mortality in diabetic nephropathy.

Authors:  L Tarnow; P Hildebrandt; B V Hansen; K Borch-Johnsen; H-H Parving
Journal:  Diabetologia       Date:  2004-12-23       Impact factor: 10.122

5.  Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction.

Authors:  K Maeda; T Tsutamoto; A Wada; T Hisanaga; M Kinoshita
Journal:  Am Heart J       Date:  1998-05       Impact factor: 4.749

6.  Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure.

Authors:  J Koglin; S Pehlivanli; M Schwaiblmair; M Vogeser; P Cremer; W vonScheidt
Journal:  J Am Coll Cardiol       Date:  2001-12       Impact factor: 24.094

7.  Ventricular dysfunction in early diabetic heart disease: detection, mechanisms and significance.

Authors:  Gerald F Watts; Thomas H Marwick
Journal:  Clin Sci (Lond)       Date:  2003-11       Impact factor: 6.124

Review 8.  A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure.

Authors:  Jenny A Doust; Paul P Glasziou; Eva Pietrzak; Annette J Dobson
Journal:  Arch Intern Med       Date:  2004-10-11

9.  High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure.

Authors:  Sanne Bruins; M Rebecca Fokkema; Jeroen W P Römer; Mike J L Dejongste; Fey P L van der Dijs; Jody M W van den Ouweland; Frits A J Muskiet
Journal:  Clin Chem       Date:  2004-09-02       Impact factor: 8.327

10.  Plasma natriuretic peptide levels and the risk of cardiovascular events and death.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Emelia J Benjamin; Eric P Leip; Torbjorn Omland; Philip A Wolf; Ramachandran S Vasan
Journal:  N Engl J Med       Date:  2004-02-12       Impact factor: 91.245
  10 in total
  1 in total

1.  Hemoglobin and B-type natriuretic peptide preoperative values but not inflammatory markers, are associated with postoperative morbidity in cardiac surgery: a prospective cohort analytic study.

Authors:  Edgar Hernández-Leiva; Rodolfo Dennis; Daniel Isaza; Juan Pablo Umaña
Journal:  J Cardiothorac Surg       Date:  2013-07-05       Impact factor: 1.637
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.